ArticleClinical transplantation2026

Post-Transplant Circulating Tumor DNA and Recurrence Risk After Liver Transplantation for Hepatocellular Carcinoma.

Sara Shahrestani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.